Compare BioNTech SE - ADR (BNTX) vs Heron Therapeutics Inc (HRTX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNTech SE - ADR vs Heron Therapeutics Inc — how do they compare? BioNTech SE - ADR trades at $92.8 (market cap $23.31B), while Heron Therapeutics Inc trades at $0.32 (market cap $61.47M). The key difference: BioNTech SE - ADR is far larger — about 379.2× Heron Therapeutics Inc's market cap, and BioNTech SE - ADR is trading nearer its 52-week high, Heron Therapeutics Inc nearer its low. Which is the better fit depends on your goals.
| BNTX | HRTX | |
|---|---|---|
Market Cap | $23.31B | $61.47M |
Sector | Health | Health |
52-Week High | $119.34 | $1.49 |
52-Week Low | $83.89 | $0.32 |
Enterprise Value | $6.60B | $168.21M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BioNTech SE - ADR
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →
